O'Brien ETF 128 being used on a patient to identify peripheral neuropathy

Biomedix to offer a free O’Brien ETF128 tuning fork with PADnet purchases for Diabetes Awareness Month

In honor of Diabetes Awareness Month this November, Biomedix is inviting all healthcare professionals to optimize care for their diabetic patients through the earlier identification of related chronic complications such as Peripheral Artery Disease (PAD), and now Peripheral Neuropathy through a new partnership with O’Brien Medical. To build on our Read more…

BeamMed Logo

Biomedix Signs Strategic Distribution Agreement With BeamMed Ltd

Expands Biomedix Xchange Population Health Management Solution Today at the RISE National 2020 Conference, BeamMed Ltd and Biomedix, LLC announce the signing of a strategic distribution agreement that expands the Biomedix Xchange Population Health Management Solution to include BeamMed’s MiniOmni bone density diagnostic technology. “The MiniOmni is an exceptionally affordable Read more…

DPNCheck Logo

Biomedix Signs Collaboration Agreement with NeuroMetrix DPNCheck

WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral neuropathy detection within Medicare Advantage and other value-based care markets.  NeuroMetrix and Biomedix provide complementary diagnostic tests to physicians and health plans. Read more…

Drug Test